Bio-Shield 2019-nCoV Total Immunoglobulins (C1348/C1396)

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Bio-Shield 2019-nCoV Total Immunoglobulins (C1348/C1396)

Principle: Double antigen sandwich ELISA method

Automation: Yes

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: For Medical Professionals and Scientists

Capital equipment required: Yes, A typical ELISA photometer

Description:

Bio-Shield 2019-nCoV Total Immunoglobulins, is a semi-quantitative ELISA test for the determination of IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

Key Points:

Semi-quantitative ELISA test with single-break strip plate with 48 wells (6 strips) or 96 wells (12 strips)
Clinical Diagnostic Sensitivity 98,68%, 75/76 (CI: 0.93 to 0.9977), Clinical Diagnostic Specificity 100%, 86/86 (CI: 0.9572 to 1)
Test time: 120 min
Compatible with automated ELISA systems
Shelf Life: 12 months | Storage 2-8 °C

Please note : Any products described on this page are for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.

Areas:

Clinical

Tags: